Profile
Full Name
Cytek Biosciences, Inc.Ticker Symbol
CTKBExchange
NASDAQSector
HealthcareIndustry
Medical DevicesCountry
United StatesIPO
July 23, 2021Indexes
Not includedWebsite
http://cytekbio.comEmployees
648Key Details
Price
$3.63(-1.23%)
Market cap
$464.35M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$200.45M(+3.85% YoY)
Annual EPS
-$0.05(+44.44% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Cytek Biosciences doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 19, 25 Stephens & Co.
OverweightMar 4, 25 Piper Sandler
OverweightNov 11, 24 Piper Sandler
OverweightAug 13, 24 Piper Sandler
OverweightMay 13, 24 Piper Sandler
OverweightMar 6, 24 Piper Sandler
OverweightFeb 29, 24 Goldman Sachs
BuyDec 14, 23 Stephens & Co.
OverweightNov 9, 23 Morgan Stanley
Equal-WeightOct 24, 23 Morgan Stanley
Equal-WeightInstitutional Ownership
- What is the ticker symbol for Cytek Biosciences?
- Does Cytek Biosciences pay dividends?
- What sector is Cytek Biosciences in?
- What industry is Cytek Biosciences in?
- What country is Cytek Biosciences based in?
- When did Cytek Biosciences go public?
- Is Cytek Biosciences in the S&P 500?
- Is Cytek Biosciences in the NASDAQ 100?
- Is Cytek Biosciences in the Dow Jones?
- When was Cytek Biosciences's last earnings report?
- When does Cytek Biosciences report earnings?
- Should I buy Cytek Biosciences stock now?
What is the ticker symbol for Cytek Biosciences?
The ticker symbol for Cytek Biosciences is NASDAQ:CTKB
Does Cytek Biosciences pay dividends?
No, Cytek Biosciences does not pay dividends
What sector is Cytek Biosciences in?
Cytek Biosciences is in the Healthcare sector
What industry is Cytek Biosciences in?
Cytek Biosciences is in the Medical Devices industry
What country is Cytek Biosciences based in?
Cytek Biosciences is headquartered in United States
When did Cytek Biosciences go public?
Cytek Biosciences's initial public offering (IPO) was on July 23, 2021
Is Cytek Biosciences in the S&P 500?
No, Cytek Biosciences is not included in the S&P 500 index
Is Cytek Biosciences in the NASDAQ 100?
No, Cytek Biosciences is not included in the NASDAQ 100 index
Is Cytek Biosciences in the Dow Jones?
No, Cytek Biosciences is not included in the Dow Jones index
When was Cytek Biosciences's last earnings report?
Cytek Biosciences's most recent earnings report was on Feb 27, 2025
When does Cytek Biosciences report earnings?
The next expected earnings date for Cytek Biosciences is May 8, 2025
Should I buy Cytek Biosciences stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions